Forbes December 17, 2025
In this week’s edition of InnovationRx, we look at the year ahead in healthcare, French healthtech Doctolib’s potential large secondary, Alice Schwartz’s legacy at Bio-Rad, and more.
The healthcare outlook for 2026: increasing AI adoption, more startup exits and ongoing regulatory challenges. That’s the bottom line from a survey of healthcare executives by Deloitte and analyst research from PitchBook.
AI technology will improve drug discovery, according to PitchBook, which predicts it will “nearly double” the number of drugs that make it through the clinical trial process, as well as shortening timelines and cutting costs. The technology will also reduce the time doctors spend on administrative tasks. The Deloitte survey echoed those findings, with 78% saying AI will play a “central...
Today's Sponsors
Today's Sponsor